Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients
Sponsor:
University of Paris 5 - Rene Descartes
Collaborators:
Information provided by (Responsible Party):
Alexandre MALMARTEL,University of Paris 5 - Rene Descartes
Tracking Information | |||
---|---|---|---|
First Submitted Date ICMJE | October 2, 2018 | ||
First Posted Date ICMJE | October 5, 2018 | ||
Last Update Posted Date | October 5, 2018 | ||
Actual Study Start Date ICMJE | January 15, 2019 | ||
Estimated Primary Completion Date | January 15, 2020 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures ICMJE |
Continuity of care[ Time Frame: over the past 1year ] Bice-Boxerman index, measuring continuity of care (from 0 to 1, 1 = good continuity of care) care pathway[ Time Frame: over the past 1 year ] the number of health care consultations with any physician (primary care, emergency department, hospitalisation), collected from the French national health insurance database |
||
Original Primary Outcome Measures ICMJE | Same as current | ||
Current Secondary Outcome Measures ICMJE |
|
||
Descriptive Information | |||
Brief Title ICMJE | Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients |
||
Official Title ICMJE | Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients |
||
Brief Summary | Chronic disease management is a public health problem that faces monitoring difficulties related to complex care pathways. This study will analyze the use of unscheduled or urgent care according to the continuity of care in multimorbid patients |
||
Detailed Description | The prevalence of chronic diseases in the population is increasing significantly. It represents a new challenge for doctors and health authorities. However, patients often have at least two chronic diseases. These are referred to as "multimorbid" patients, whose continuity of care has not been well studied to date. This observational study evaluates the association between the continuity of care in multimorbid patients seen in general practice and their use of urgent healthcare, their quality of life and their burden of treatment. | ||
Study Type ICMJE | Observational | ||
Study Phase | |||
Study Design ICMJE | Allocation: Intervention Model: Intervention Model Description: Masking: Observational Masking Description: Primary Purpose: |
||
Condition ICMJE | |||
Intervention ICMJE |
|
||
Study Arms |
|
||
Recruitment Information | |||
Recruitment Status ICMJE | Not yet recruiting | ||
Estimated Enrollment ICMJE |
600 | ||
Original Estimated Enrollment ICMJE | Same as current | ||
Estimated Study Completion Date | June 15, 2020 | ||
Estimated Primary Completion Date | January 15, 2020 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria ICMJE | Inclusion Criteria: - over 18 years of age, seen in consultation in the office by an investigating doctor, with a follow-up for more than 12 months in the office, presenting at least two chronic disease , having given their written consent to participate in the study Exclusion Criteria: - seen at home - unable to respond (cognitive problems or language barrier) | ||
Sex/Gender |
|
||
Ages | 18 Years and older (Adult, Older Adult) | ||
Accepts Healthy Volunteers | No | ||
Listed Location Countries ICMJE | |||
Removed Location Countries | |||
Administrative Information | Has Data Monitoring Committee | No | |
U.S. FDA-regulated Product |
Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No |
||
IPD Sharing Statement |
|
||
Responsible Party | Alexandre MALMARTEL,University of Paris 5 - Rene Descartes | ||
Study Sponsor ICMJE | University of Paris 5 - Rene Descartes | ||
Collaborators ICMJE | |||
Investigators ICMJE |
|
||
PRS Account | University of Paris 5 - Rene Descartes | ||
Verification Date | October 2018 | ||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
请使用微信扫码报名